- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02715349
Psychoeducation for Vietnamese Families With a Patient With Schizophrenia
March 16, 2016 updated by: Danang Psychiatric Hospital
Families with a patient with schizophrenia and the patient are randomly assigned to receive either a 3 session psychoeducation program, or no psychoeducation.
Other treatment for schizophrenia and other mental illness are provided as usual.
Study Overview
Detailed Description
Families with a patient with schizophrenia and the patient are randomly assigned to receive either a 3 session psychoeducation program, or no psychoeducation.
Other treatment for schizophrenia and other mental illness are provided as usual.
The psychoeducation program focuses on: (a) explaining schizophrenia as a medical, biological illness, (b) the prognosis for schizophrenia (e.g., that it is possible to lead a normal life), and (c) what the family and patient can do to maximize the outcome.
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Danang, Vietnam
- Danang Psychiatric Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of schizophrenia, based on ICD-10
- Receive in-patient treatment at hospital
- Length of schizophrenia less than 3 years.
- Treated 3 or less times for schizophrenia.
Exclusion Criteria:
- Mental retardation, or other diagnoses that could affect the ability to answer questionnaires, after the acute schizophrenia psychosis is controlled.
- Suicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychoeducation
3 session psychoeducation program with the family, and 3 session psychoeducation program with the patient, after psychosis is controlled.
Psychoeducation focuses on explaining schizophrenia as a medical illness, the prognosis, and how the patient and family can increase the likelihood of better outcome.
|
3 session psychoeducation program with the family, and 3 session psychoeducation program with the patient, after psychosis is controlled.
Psychoeducation focuses on explaining schizophrenia as a medical illness, the prognosis, and how the patient and family can increase the likelihood of better outcome.
|
|
No Intervention: Control
Family and patient do not receive psychoeducation, but still receive standard hospital services for schizophrenia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline (pre-treatment) to 6 months post-baseline in patient-report of quality of life using the Quality of Life Enjoyment and Satisfaction Questionnaire.
Time Frame: baseline (pre-treatment). six months post-baseline.
|
Change in quality of life using an Analysis of Covariance with the baseline quality of life score as the covariate, the 6 month quality of life assessment as the dependent variable, and treatment group as the independent variable.
The Quality of Life Enjoyment and Satisfaction Questionnaire with patient-report is used at both timepoints.
|
baseline (pre-treatment). six months post-baseline.
|
|
Change from baseline (pre-treatment) at 6 months post-baseline in family-report of quality of life using the Quality of Life Enjoyment and Satisfaction Questionnaire.
Time Frame: baseline (pre-treatment). six months post-baseline.
|
Change in quality of life using an Analysis of Covariance with the baseline quality of life score as the covariate, the 6 month quality of life assessment as the dependent variable, and treatment group as the independent variable.
The Quality of Life Enjoyment and Satisfaction Questionnaire with family-report is used at both timepoints.
|
baseline (pre-treatment). six months post-baseline.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline (pre-treatment) to 6 months post-baseline in patient-report of stigma towards schizophrenia using the Stigma Towards Schizophrenia questionnaire.
Time Frame: baseline (pre-treatment). six months post-baseline.
|
Change in stigma towards schizophrenia using an Analysis of Covariance with the baseline stigma towards schizophrenia as the covariate, the 6 month stigma towards schizophrenia assessment as the dependent variable, and treatment group as the independent variable.
The Stigma Towards Schizophrenia with patient-report is used at both timepoints.
|
baseline (pre-treatment). six months post-baseline.
|
|
Change from baseline (pre-treatment) to 6 months post-baseline in family-report of stigma towards schizophrenia using the Stigma Towards Schizophrenia questionnaire.
Time Frame: baseline (pre-treatment). six months post-baseline.
|
Change in stigma towards schizophrenia using an Analysis of Covariance with the baseline stigma towards schizophrenia as the covariate, the 6 month stigma towards schizophrenia assessment as the dependent variable, and treatment group as the independent variable.
The Stigma Towards Schizophrenia with family-report is used at both timepoints.
|
baseline (pre-treatment). six months post-baseline.
|
|
Patient-report for schizophrenia medication compliance, at 6 months post-baseline
Time Frame: 6 months post-baseline
|
Analysis of Variance on medication compliance as reported by the patient
|
6 months post-baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-report satisfaction with hospital services, at 6 months post-baseline
Time Frame: 6 months post-baseline
|
Patient-report satisfaction with services provided by the hospital.
|
6 months post-baseline
|
|
Family-report satisfaction with hospital services, at 6 months post-baseline
Time Frame: 6 months post-baseline
|
Family-report satisfaction with services provided by the hospital.
|
6 months post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ngoc Tran, MD, Danang Psychiatric Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
March 3, 2016
First Submitted That Met QC Criteria
March 16, 2016
First Posted (Estimate)
March 22, 2016
Study Record Updates
Last Update Posted (Estimate)
March 22, 2016
Last Update Submitted That Met QC Criteria
March 16, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DPH20140818
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
Clinical Trials on Psychoeducation
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
The University of Texas Health Science Center,...TerminatedBipolar Disorder Family MembersUnited States
-
The Hong Kong Polytechnic UniversityHealth and Medical Research FundNot yet recruitingCaregiving Stress
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAlzheimer's Association; University of BergamoCompleted
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
University of Alabama at BirminghamCompletedChronic Low Back PainUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Virginia; Autism Speaks; National Center for Advancing Translational...CompletedAutism Spectrum DisorderUnited States
-
Istanbul Medeniyet UniversityCompletedElderly People | Depressive Symptoms | DespondencyTurkey
-
University of Missouri, Kansas CityUniversity of KansasCompletedMultiple SclerosisUnited States
-
Uppsala UniversityCompleted